ADS Biotec, along with its parent company ADSTEC (Japan), is a global leader in the development, manufacture and sale of automated instruments and consumables for use in cytogenetic, pathology and research laboratories.
ADS Biotec recognized by Governor Pillen on October 2 at Bio Nebraska's Annual event ADS Biotec was announced as the 2025 recipient of the Governor's Bioscience Award, presented by Governor Jim Pillen. The award, which recognizes individuals and companies making significant contributions to the Nebraska bioscience industry, was given during an award presentation ceremony at [...]
ADS Biotec Launches White Paper on Revolutionary use of HANABI AVATAR™ Organoid Growth Media January 23, 2025 – Omaha, USA: ADS Biotec, a global leader in development of automated solutions and consumables for use in cytogenetic, pathology and research laboratories is pleased to announce the release of its latest white paper titled “Use of HANABI […]
PRESS RELEASE ADS Biotec Launches HANABI P7 High-Capacity Metaphase Auto Spreader May 29, 2024 – Omaha, USA: ADS Biotec, a global leader in development of automated instruments and bio-consumables that increase productivity for Cytogenetic, Pathology, and Molecular Genetics in clinical and research laboratories is pleased to introduce the HANABI P7 High-Capacity Metaphase Auto Spreader. The […]
PRESS RELEASE ADS Biotec Launches HANABI Avatar™ Organoid Growth Media January 09, 2023 – Omaha, USA: ADS Biotec, is a global leader in development of automated instruments and bio-consumables to increase productivity for Cytogenetic, Pathology, and Molecular Genetics in clinical and research laboratories is pleased to announce immediate availability of its HANABI Avatar™ Organoid Growth Medias, […]
ADS Biotec – Genetic Solutions/Service Company ADS Biotec has a global footprint with offices in the U.S., Europe, and Japan, with customers in over 30 countries and more that 250 active installations in leading medical facilities, diagnostic labs and academic research labs. Having established itself within the genetics discipline, its product line, HANABI, is recognized as [...]
ADS Biotec Receives ISO 13485:2016 Quality System Certification ISO 13485 certification indicates that the company’s quality management system meets the most current regulatory requirements specific to the international medical device industry. Read More HANABI Cytogenetic Automation Instruments with CE-IVD Mark ADSTEC along with its subsidiary ADS Biotec now offer a range of HANABI Cytogenetic Automation [...]
Innovative and cost-effective automation with its game-changing solutions, ADS Biotec offers robust solutions that can solve the service challenges for laboratories. A global leader in the field of automated instruments, its team designs, produces, and distributes automated systems and supplies used in cytogenetic, pathology, and research labs, along with producing custom solutions. Its automated technology and […]
PRESS RELEASE Ads Biotec receives ISO 13485:2016 Quality System Certification ISO 13485 certification indicates that the company’s quality management system meets the most current regulatory requirements specific to the international medical device industry. January 16, 2023 – Omaha, USA: ADS Biotec, a global leader in development of automated instruments and bio-consumables including buffers for mRNA […]
ADS Biotec strengthens its Scientific Advisory Board with appointments of new board members. Appointment of two new Scientific Advisory Board members will help to guide the company’s ambitious growth plans. March 2, 2023 – Omaha, USA: ADS Biotec, a global leader in development of automated instruments and bio-consumables including buffers for mRNA purification, is […]
ADSTEC along with its subsidiary ADS Biotec now offer a range of HANABI Cytogenetic Automation Instruments with CE-IVD mark. September 27, 2022 –Tokyo, Japan and Omaha, USA: ADSTEC and its subsidiary ADS Biotec, a global leader in development of automated instruments and consumables for use in cytogenetic, pathology and research laboratories is pleased to announce […]
